H.C. Wainwright Maintains ITeos Therapeutics(ITOS.US) With Buy Rating, Maintains Target Price $21

Moomoo NewsJan 16 06:31 ET · Ratings

ITeos Therapeutics: Promising Phase 2 Data Boosts Buy Rating on Lead Asset Belrestotug Combination

TipRanksJan 16 06:26 ET · Ratings

ITeos Therapeutics Outlines Business Updates, Strategies for 2025

TipRanksJan 10 07:21 ET

Express News | Iteos Therapeutics Inc - Eos-215 Ind Submission Anticipated in 1Q25

ReutersJan 10 07:00 ET

Express News | Iteos Therapeutics Inc - Eos-984 Phase 1 Monotherapy and Pd-1 Combination Data Expected in 2H25

ReutersJan 10 07:00 ET

Express News | Iteos Therapeutics Inc - Cash Balance of $683.9 Million Expected to Provide Runway Through 2027

ReutersJan 10 07:00 ET